PUBLISHER: The Business Research Company | PRODUCT CODE: 1478538
PUBLISHER: The Business Research Company | PRODUCT CODE: 1478538
Gene delivery technologies encompass a diverse range of methods utilized to introduce genetic material into target cells or organisms for various applications, including gene therapy, genetic engineering and research purposes. These technologies are crucial for manipulating genetic information, enabling the delivery of therapeutic genes, gene editing tools or genetic constructs into cells to modulate gene expression or correct genetic defects.
The gene delivery technologies market consists of revenues earned by entities (organizations, sole traders or partnerships) primarily engaged in the development, production and distribution of techniques and systems for delivering genetic material. These technologies find extensive applications in biopharmaceuticals, agriculture, research and other fields.
The global gene delivery technologies market was valued at $2,159.64 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.
Growing Investments In Research And Development
During the historic period, the gene delivery technologies market was mainly driven by the growing investments in research and development. The investment in research and development (R&D) is growing due to technological advancements, global competition, market demand, regulatory pressures, global challenges, access to capital and the recognition of R&D as a key driver of long-term growth and competitiveness. This investment helps gene delivery technologies by enabling the development of new and improved delivery systems, enhancing targeting capabilities, improving safety profiles and expanding the range of applications, ultimately leading to more effective and personalized treatments for various diseases, including genetic disorders and cancer. For instance, according to the National Center for Science and Engineering Statistics, a US-based government agency, in 2022, state government agencies reported a total expenditure of $2.644 billion on research and experimental development (R&D). This represents a 5.2% increase from the previous year's expenditures of $2.513 billion. Therefore, growing investments in research and development contributed to the growth of the gene delivery technologies market.
Innovative Advancements To Improve Gene-Editing Technologies
Companies in the gene delivery technologies market are developing innovative products such as QIAprep& CRISPR Kit to provide rapid and sensitive characterization of clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing events in mouse or rat cells. The QIAprep& CRISPR Kit offers a streamlined workflow that includes liquid-based sample preparation, custom primer design, amplification of the region of interest and quantification of editing efficiency. For instance, in June 2021, Qiagen, a Germany-based genomics company, launched QIAprep& CRISPR Kit. This launch by QIAGEN represents a significant advancement in gene-editing technologies, providing researchers with efficient tools for analyzing and characterizing gene-editing events with high precision and sensitivity.
The global gene delivery technologies market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 67.3% of the total market in 2022.
Gene Delivery Technologies Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global gene delivery technologies market as it emerges from the COVID-19 shut down.
Where is the largest and fastest-growing market for gene delivery technologies market? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The gene delivery technologies market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider gene delivery technologies market; and compares it with other markets.
Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by mode, by method and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.